Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
22
BOVNF Quote, Financials, Valuation and Earnings
Last price:
$3.29
Seasonality move
:
-3.09%
Day range:
$3.29 - $3.29
52-week range:
$3.29 - $4.70
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.69x
P/B ratio:
2.98x
Volume:
--
Avg. volume:
--
1-year change:
-30.03%
Market cap:
$216.4M
Revenue:
$4.2M
EPS (TTM):
-$0.48
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, BioInvent International AB has -- downside to fair value with a price target of -- per share.
BOVNF vs. S&P 500
-
Over the past 5 trading days, BioInvent International AB has underperformed the S&P 500 by -0.31% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
BioInvent International AB does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
BioInvent International AB revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter BioInvent International AB reported revenues of $348.9K.
Earnings Growth
-
BioInvent International AB earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter BioInvent International AB reported earnings per share of -$0.21.
Enterprise value:
144.1M
EV / Invested capital:
1.95x
Price / LTM sales:
8.69x
EV / EBIT:
--
EV / Revenue:
5.79x
PEG ratio (5yr expected):
-0.12x
EV / Free cash flow:
-5.67x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-33.88%
Net Income Margin (TTM):
-125.81%
Return On Equity:
-37.89%
Return On Invested Capital:
-37.24%
Operating Margin:
-4030.98%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $7.2M | $3.7M | $24.9M | $1.2M | $348.9K | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$31.9M | -$43.3M | -$33.6M | -$10.3M | -$14.1M | |
| EBITDA | -$30.4M | -$41.5M | -$31.7M | -$9.9M | -$13.6M | |
| Diluted EPS | -$0.45 | -$0.59 | -$0.48 | -$0.14 | -$0.21 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $146.3M | $114.4M | $113.1M | $99.7M | $79.6M | |
| Total Assets | $173.8M | $158.2M | $136.5M | $107.3M | $83.6M | |
| Current Liabilities | $5.9M | $4.8M | $5.8M | $7.5M | $10.8M | |
| Total Liabilities | $8.5M | $6.4M | $7.1M | $8.3M | $10.9M | |
| Total Equity | $165.2M | $151.8M | $129.4M | $99M | $72.6M | |
| Total Debt | $3.4M | $2.1M | $2M | $1.7M | $1.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$32.1M | -$33.6M | -$24.7M | -$9.3M | -$11M | |
| Cash From Investing | $19.3M | $46.6M | $3.9M | $33.5M | $19.1M | |
| Cash From Financing | $2.3M | -$785.1K | -$894.4K | -$200.2K | -$244.2K | |
| Free Cash Flow | -$33.6M | -$34.7M | -$25.4M | -$9.5M | -$11.2M | |
BOVNF
Sector
Market Cap
$216.4M
$28.5M
Price % of 52-Week High
69.97%
51.44%
Dividend Yield
0%
0%
Shareholder Yield
0.06%
-1.33%
1-Year Price Total Return
-30.03%
-20.32%
Beta (5-Year)
6.936
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$3.29
200-day SMA
Sell
Level
$3.82
Bollinger Bands (100)
Sell
Level
3.29 - 3.29
Chaikin Money Flow
Sell
Level
-5.5K
20-day SMA
Sell
Level
$3.29
Relative Strength Index (RSI14)
Sell
Level
0.00
ADX Line
Sell
Level
100
Williams %R
Buy
Level
-100
50-day SMA
Sell
Level
$3.29
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Sell
Level
0
On Balance Volume
Sell
Level
-459.1K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (15.1731)
Buy
CA Score
(Annual)
Level (-0.2835)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (6.3434)
Sell
Piotroski F Score
(Annual)
Level (2)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
BioInvent International AB is a clinical-stage biotech company that discovers and develops novel and immuno-modulatory antibodies for cancer therapy. Its technology platforms include F.I.R.S.T. and n-CoDeR. The company was founded in 1996 and is headquartered in Lund, Sweden.
Stock Forecast FAQ
In the current month, BOVNF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BOVNF average analyst price target in the past 3 months is --.
-
Where Will BioInvent International AB Stock Be In 1 Year?
According to analysts, the consensus estimate is that BioInvent International AB share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About BioInvent International AB?
Analysts are divided on their view about BioInvent International AB share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that BioInvent International AB is a Sell and believe this share price will rise from its current level to --.
-
What Is BioInvent International AB's Price Target?
The price target for BioInvent International AB over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is BOVNF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for BioInvent International AB is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of BOVNF?
You can purchase shares of BioInvent International AB via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase BioInvent International AB shares.
-
What Is The BioInvent International AB Share Price Today?
BioInvent International AB was last trading at $3.29 per share. This represents the most recent stock quote for BioInvent International AB. Yesterday, BioInvent International AB closed at $3.29 per share.
-
How To Buy BioInvent International AB Stock Online?
In order to purchase BioInvent International AB stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get BOVNF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BOVNF
Sector
P/E ratio
--
23.75x
PEG ratio
-0.12x
-0.01x
P/B ratio
2.98x
1.83x
Price / LTM sales
8.69x
1.60x
Growth Metrics
BOVNF
Sector
Revenue growth
-71.51%
4.85%
Earnings growth
-45.49%
11.11%
Revenue (5-year growth)
-15.67%
6.45%
Earnings forecast
--
-$0.20
Profitability
BOVNF
Sector
Profitability FY 2024
--
$3.6M
Return on invested capital
-37.24%
-30.98%
Return on assets
-33.88%
-27.62%
Return on equity
-37.89%
-36.69%
Earnings Date
Last Earnings Date
Oct
29
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Jan
28
Balance Sheet
BOVNF
Sector
Total cash
$73.4M
$27.2M
Short term investments
$39.2M
$25.7M
Total assets
$89.5M
$79.7M
Long term debt
$1.1M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
